It has been shown that mechanical ventilation by itself can cause lung injury and affect outcomes. Ventilator-induced lung injury is associated with high tidal volumes in lungs afflicted with ARDS. However, the question is: Do high tidal volumes have this same effect in normal lungs or lungs that have respiratory compromise stemming from something other than ARDS? Many clinicians believe that a tidal volume strategy of 6 mL/kg predicted body weight should be standard practice in all patients receiving mechanical ventilation. There is a growing body of evidence related to this issue, and this is the debate that will be tackled in this paper from both pro and con perspectives. Key words: tidal volume; predicted body weight; mechanical ventilation; lung-protective ventilation; time constant; ARDS; stress; strain; hypercapnia. [Respir Care 2016;61(6):774 -790
Introduction
It is well known that the use of mechanical ventilation has the potential to aggravate pulmonary injury, but emerging evidence indicates that it may also precipitate lung injury in patients with no previous injury. Lung-protective ventilation has evolved over the past couple of decades to the point that it has become standard of care for patients with ARDS. The use of lower tidal volume (V T ) values, 4 -8 mL/kg predicted body weight (PBW) is part of this lung-protective strategy for mechanical ventilation (mechanical ventilation) along with limiting the plateau pressure to a maximum of 30 cm H 2 O and prudent use of PEEP to prevent atelectasis. Since we now know that the use of lower V T strategies (more specifically 6 mL/kg PBW) helps to limit the pulmonary damage during ARDS, the question now is: Should we be using this strategy in all mechanically ventilated patients? Anatomically speaking, it makes sense to, since the normal physiologic V T for humans is approximately 6 mL/kg PBW. 1 There is a growing body of evidence that points toward the use of lower V T values leading to improved outcomes in patients suffering from other forms and degrees of respiratory failure. The aim of this paper is to examine the evidence relating to the use of lower V T values in conditions other than ARDS in which mechanical ventilation is required. This will be done with viewpoints from both the pro and con positions.
Early Studies
There is a plethora of preclinical evidence from animal studies supporting the fact that the use of high V T values can directly cause injury to normal lungs. Animal studies have shown that high V T ventilation increases levels of pro-inflammatory mediators, leads to pulmonary edema, and causes increased alveolar-capillary permeability and structural abnormalities. [2] [3] [4] [5] [6] [7] [8] With the emergence of these animal data, clinicians began to question the traditional use of V T values in the range of 10 -15 mL/kg PBW in humans. Several small human studies were reported in the mid-to late 1990s that produced conflicting results. [9] [10] [11] These studies were hampered by several factors, including higher than predicted mortality in the control group, a relatively small difference in V T between the groups, insufficient statistical difference to detect a signal, and uncorrected acidosis in the low V T group. However, in 2000, a landmark study comparing lower V T values (6 mL/kg PBW) with higher V T values (12 mL/kg PBW) in ARDS was undertaken by the ARDS Net group. It was a large multi-center prospective randomized trial with Ͼ800 subjects enrolled. The study was stopped early after an interim analysis revealed a survival advantage of 22% in the lower V T group. 12 Since the publication of this study, there has been a growing body of evidence that suggests that the use of lower V T values may also improve clinical outcomes in patients without ARDS.
Ventilation of Patients Who Do Not Have ARDS
Although mechanical ventilation strategies are slowly gravitating toward the use of lung-protective ventilation, many clinicians have not adopted the practice in all patients. The use of high V T values in patients with ARDS clearly appears to be detrimental in that it rapidly results in pulmonary changes that mimic and amplify the ARDS inflammatory process. 2, 12 The biophysical injury in ARDS lungs consists of overdistention of recruited alveoli, direct cell damage due to cyclical opening and closing of unstable alveoli, and loss of surfactant function. 13 What we do not know for sure is whether higher V T values have this on effect on normal lungs.
Shortly after the ARDS Net study in 2000, Gajic et al 14 conducted a retrospective cohort study of 332 medicalsurgical subjects receiving mechanical ventilation for Ͼ48 h who did not have acute lung injury (ALI) at the onset of mechanical ventilation. They found that 80 subjects (24%) developed ALI within the first 5 d and, on average, within the first 3 d. 14 They concluded that there existed 2 important risk factors for the development of ALI: large V T values and the administration of blood products. Figure 1 illustrates that, as V T increased, the ALI rate also increased. 14 The same group then followed up with an analysis of a large international mechanical ventilation database of subjects who received mechanical ventilation for Ͼ48 h but did not have ARDS at the outset. Of 3,261 subjects, 205 (6.2%) developed ARDS. The initial ventilator settings, in particular the V T , were associated with the development of ARDS. 15 Of note, as was the case with the ARDSNet study, the initial static respiratory system compliance was better in the group that went on to develop ARDS (higher V T group). Thus, it is important to keep in mind that the use of surrogate end points, such as compliance, do not necessarily correlate to mortality.
Mascia et al 16 conducted a prospective, observational study of 82 mechanically ventilated subjects with severe brain injury but with otherwise healthy lungs. In this population, 18 subjects (22%) developed ALI. The subjects with ALI were initially ventilated with a significantly higher V T (10.4 mL/kg) compared with subjects without ALI. Fig. 1 . Proportion of acute lung injury (ALI) with respect to tidal volume (V T ). V T Ͻ9 mL/kg predicted body weight (PBW) (n ϭ 66), V T ϭ 9 -12 mL/kg PBW (n ϭ 160), and V T Ͼ12 mL/kg PBW (n ϭ100). Adjusted P value from a multiple logistic regression model; V T was treated as a continuous variable. From Reference 14, with permission.
Risk factors for ALI were V T , breathing frequency, and expiratory minute volume. Later, the same group examined 118 subjects who were deemed potential organ donors. This was a randomized controlled trial in 12 European ICUs that compared conventional ventilation (V T ϭ 10 -12 mL/kg and 3-5-cm H 2 O PEEP) with protective ventilation (V T ϭ 6 -8 mL/kg and 8 -10-cm H 2 O PEEP). The results revealed an dramatic increase in the number of eligible lung donors: 32 (54%) versus only 16 (27%, P ϭ .004) in the conventional group, suggesting that lower V T values may have a role in lung preservation. 17 In a large prospective randomized controlled trial, Determann et al 18 compared the use of 6 mL/kg PBW V T with 10 mL/kg PBW V T in 150 mechanically ventilated intensive care subjects. The trial was stopped early because the rate of lung injury development was 13.5% in the 10 mL/kg V T group compared with only 2.6% in the 6 mL/kg V T group. The investigators also found significantly higher lavage fluid cytokine levels in the 10 mL/kg V T group. Also, the 6 mL/kg PBW group did not require additional sedation or hemodynamic support. 18 In a smaller randomized controlled trial of 20 subjects without lung disease, the subjects received either V T values of 5-7 mL/kg PBW or 10 -12 mL/kg PBW in the ICU setting. Tumor necrosis factor alpha and interleukin 8 were measured in both the serum and bronchoalveolar lavage fluid at admission and then again at 12 h. Whereas levels of both tumor necrosis factor alpha and interleukin 8 increased initially, the pulmonary inflammatory response in the low V T group became attenuated at 12 h. 19 A secondary analysis of 3 prospective observational multi-center studies from 1998, 2004, and 2010 looked at ventilator management and complications over that span. A total of 812 subjects who received mechanical ventilation after cardiac arrest were studied. The group found that the use of protective ventilation increased from 1998 to 2010, and pulmonary complications decreased in that time span. 20 The investigators concluded that the use of higher V T was a potential risk factor for developing pneumonia and ARDS. 20 In 2012, Serpa Neto et al 21 performed a meta-analysis of 20 studies, 15 of which were randomized controlled trials (2,822 subjects receiving mechanical ventilation who did not have ARDS initially). They found evidence that the use of lower V T was associated with a lower risk of developing ARDS, lower mortality rate, fewer pulmonary infections, and a shorter hospital stay. The same group followed up with a patient-specific meta-analysis of mechanically ventilated subjects without ARDS at the onset of ventilation. The meta-analysis included 5 randomized controlled trials and 5 observational studies. The subjects were stratified into 3 groups: (1) V T Յ6 mL/kg PBW, (2) V T ϭ 6 -10 mL/kg PBW, and (3) V T Ն10 mL/kg PBW. The findings of this study were that V T values Յ6 mL/kg PBW were associated with more subjects breathing without assistance at day 28 and more ventilator-free days. 22 The Serpa Neto group then went on to perform a third meta-analysis in 2015 23 with the primary outcome being pulmonary complications (ARDS and pneumonia) in subjects without ARDS at the time of intubation. As in the previous meta-analysis, they stratified the subjects into 3 groups: (1) V T Ն10 mL/kg PBW, (2) V T Ͼ7 and Ͻ10 mL/kg PBW, and (3) V T Յ7 mL/kg PBW) during the first 2 d of mechanical ventilation. The results are depicted in Table  1 . The results suggested a strong correlation for protective ventilation and low V T values in that the risk of pulmonary complications decreased by 28% in the low V T group compared with the high V T group (P ϭ .042). 23 The development of pulmonary complications was associated with a lower number of ICU-free and hospital-free days (10.0 Ϯ 10.9 d vs 13.8 ϩ 11.6 d, P Ͻ .001) and increases in hospital mortality (49.5 vs 35.6, P Ͻ .001). 23 The results also suggested a dose-response relationship between the size of the V T and the development of pulmonary complications. 23 The evidence presented above is suggestive of the fact that larger V T values lead to increases in pulmonary proinflammatory mediators and pulmonary complications in ICU patients who do not initially present with ARDS. However, large randomized controlled trials are needed to better establish the use of low V T values in this patient population. More liberal use of low V T values certainly, however, seems warranted for those patients who have risk factors for the development of ARDS.
Ventilation of Surgical Patients
Postoperative pulmonary complications have been associated with increases in morbidity and mortality in patients undergoing major surgery. 24 Postoperative ARDS represents the worst pulmonary complication, and its occurrence has been estimated as high as 25%. [25] [26] [27] Increases in morbidity and mortality may be, at least somewhat, attributable to the practice of historically using high V T in the range of 10 -15 mL/kg PBW and no PEEP. This prac- tice of using high V T without PEEP in the operating room was introduced back in 1963 as a means of improving oxygenation and avoiding atelectasis and remains as a strategy still being used by many today. 28 Despite the publication of the ARDSNet landmark paper in 2000 showing that lower V T resulted in a mortality benefit as compared with the traditional V T of 12 m/kg PBW, this strategy has been slow to be employed in the surgical arena. 29 However, over the past decade, there have been encouraging indications that lung-protective ventilation is being used more frequently in the operating room. 30 Since many surgical procedures are of relatively short duration, the focus on lung-protective ventilation is placed on the back burner by many anesthesiologists. However, it has been shown that pulmonary inflammatory damage can occur after only a few hours. 31 Although information about the pulmonary side effects of mechanical ventilation in the operating room has historically been limited, there are a growing number of studies showing that the use of high V T values in surgical patients has deleterious effects. Schilling et al 32 studied 32 subjects undergoing open thoracic surgery and compared the use of low V T (5 mL/kg PBW) versus high V T (10 mL/kg PBW) strategies. They found that in all subjects, there was an increase in pro-inflammatory mediators. However, several of the pro-inflammatory markers (tumor necrosis factor alpha and soluble intercellular adhesion molecule 1) were significantly decreased in the low V T group over time. The authors concluded that the use of mechanical ventilation may promote the production and release of pro-inflammatory substances in the alveoli, resulting in epithelial damage. They further concluded that the use of lower V T values may aid in decreasing some of the pro-inflammatory mediators. 32 Michelet et al 33 prospectively investigated 52 subjects who underwent an esophagectomy, comparing high (9 mL/kg PBW) and low V T (5 mL/kg PBW) strategies. As was the case in the study by Schilling et al, 32 the lower V T group had lower blood levels of pro-inflammatory mediators, improved P aO 2 /F IO 2 , and a reduction in the duration of intubation. Another study also examined the relationship between the size of the V T and the pro-inflammatory response in subjects undergoing various surgical procedures lasting Ն5 h. Wolthuis et al 34 compared high V T (12 mL/kg) and no PEEP with protective ventilation of 6 mL/kg and 10-cm H 2 O PEEP and found that the use of lower V T attenuated the increase of pulmonary levels of pro-inflammatory mediators.
It certainly appears from the above mentioned studies that there is an increase in pulmonary inflammation that is associated with mechanical ventilation and that using lower V T values seems to have the potential to attenuate this inflammatory response. Whether this translates into a mortality outcome benefit remains to be seen.
Several investigators have studied the association between V T size and the development of postoperative respiratory complications. Futier et al 35 studied 400 subjects undergoing abdominal surgery who were at risk of developing postoperative pulmonary complications and assigned the subjects to receive either non-protective ventilation (V T ϭ 10 -12 mL/kg PBW and no PEEP) or lung-protective ventilation (V T ϭ 6 -8 mL/kg PBW and PEEP ϭ 6 -8 cm H 2 O along with recruitment maneuvers). They found that pulmonary complications occurred in 27.5% of the subjects in the non-protective group compared with only 10.5% in the protective group (P Ͻ .001). In addition, the lung-protective strategy resulted in a 69% reduction in the number of subjects requiring ventilator support within the first 7 days after surgery. Severgnini et al 36 compared the use of a traditional ventilation strategy (V T ϭ 9 mL/kg PBW and no PEEP) with a lung-protective strategy (V T ϭ 7 mL/kg PBW with PEEP ϭ 10 cm H 2 O and recruitment maneuvers) in 56 subjects scheduled to undergo elective open abdominal surgery lasting Ͼ2 h and found that subjects in the lung-protective group had better pulmonary function tests up to day 5, fewer alterations in chest radiographs up to day 3, better oxygenation, and a lower clinical pulmonary infection score. Ladha et al 37 performed a large (69,265 subjects) hospital-based registry study in 3 Massachusetts hospitals from January 2007 to August 2014. They compared subjects who received protective mechanical ventilation (V T Ͻ10 mL/kg PBW, PEEP Ն5 cm H 2 O, and plateau pressure Ͻ30 cm H 2 O) with subjects who received non-protective mechanical ventilation in terms of postoperative respiratory complications during non-cardiac surgery. They found that using protective mechanical ventilation intra-operatively was associated with a significantly lower risk of postoperative respiratory complications and that it was the V T (as opposed to PEEP and plateau pressure) that had the most beneficial effect difference. Fernandez-Perez et al 38 performed a retrospective analysis of 170 subjects who underwent pneumonectomies. The results showed that 18% of the subjects developed respiratory failure and 50% developed ALI. These subjects had higher V T values than those who did not develop respiratory failure (8.3 vs 6.7 mL/kg PBW, P Ͻ .001).
There are a couple of recent meta-analyses that examined the effects low V T strategies during mechanical ventilation in surgery. Zhang et al 39 performed a systematic review of 22 studies of subjects undergoing general anesthesia during major surgery and the development of ALI. They found that lower V T ventilation was associated with a protective effect against the development of ALI. Likewise, Gu et al 40 performed a recent meta-analysis that included 19 randomized controlled trials in 1,348 subjects undergoing surgery and compared the subjects who received lung-protective ventilation (5-8 mL/kg PBW) with those who received traditional mechanical ventilation. There was a decreased incidence of lung injury and pulmonary infections in the lung-protective mechanical ventilation group (Fig. 2) . 33, 35, [40] [41] [42] [43] [44] [45] [46] Cardiac surgery with cardiopulmonary bypass in and of itself is associated with a systemic and pulmonary inflammation. 47 Cardiopulmonary bypass-related systemic inflammatory response syndrome represents an important first hit for lung injury, and the use of high V T values during the surgery may act as the second hit that worsens lung damage. Two studies looked at the effect of low V T strategy on pulmonary pro-inflammatory mediators in this patient population. Zupancich et al 31 studied the effect of V T on interleukin 6 and 8 levels in the bronchoalveolar lavage fluid and plasma in 40 subjects undergoing elective coronary artery bypass. They found that, whereas the levels of interleukin 6 and 8 increased in both the low and high V T groups, they leveled off in the low V T group while they kept increasing in the high V T group (Fig. 3) . Miranda et al 48 also looked at the effect of V T on pro-inflammatory mediators in 62 subjects undergoing coronary artery bypass. Their results mirrored those of Zupancich in that there was an initial increase in levels of pro-inflammatory mediators in all subjects, but it became attenuated in the low V T group. 28 In a large study Lellouche et al 49 examined consecutively 3,434 subjects who underwent cardiopulmonary bypass and the immediate postoperative V T values. A multivariate analysis revealed that larger V T values were associated with longer time on mechanical ventilation and prolonged times in the ICU (Table 2) as well as hemodynamic instability.
Other outcome measurements have been used in comparing high versus low V T during cardiac surgery. Sundar et al 50 examined the time to extubation for cardiac surgical subjects receiving either 6 mL/kg or 10 mL/kg PBW. They found that, although the time to extubation did not significantly decrease, significantly more subjects in the lower V T group were extubated and breathing without assistance 6 -8 h after surgery. They also noted that the lower V T group had a lower incidence of re-intubation.
Although the above studies make a convincing argument for the use of lower V T values in the operating room, well-powered randomized controlled trials are still needed to better establish the clinical effect of intra-operative lungprotective ventilation. However, until this occurs, physiologic data strongly suggest that the low V T strategy is safer and more protective than traditional V T values.
Concerns About Using Low V T
Indeed, there are concerns about using lower V T values during mechanical ventilation. Among them are the po- tential for hypercapnia, patient-ventilator asynchrony, and increased sedation use. Hypercapnia is a real possibility when clinicians use a low V T strategy. However, increases in set breathing frequency can offset this as long as auto-PEEP is not created. There are a number of studies that have actually shown beneficial effects of permissive hypercapnia in that it may have the potential to attenuate lung injury. [51] [52] [53] [54] Some have even suggested that hypercapneic acidosis could be therapeutic as opposed to permissive. 55 However, the degree of permissive hypercapnia that can be used safely during low V T ventilation is unclear, but it may be that a mild acidosis should be tolerated to enable the use of lower V T values. Patient-ventilator asynchrony is also a potential issue with the use of lower V T values, especially in volume assist control with a fixed flow. The smaller V T values may result in shorter inspiratory times, which may create a mismatch with the patient's neural timing. However, with technological advances, today's mechanical ventilators now have advanced graphic packages that depict the waveforms in great detail. This equips the clinician to be better able to identity patientventilator asynchrony and act to minimize it through ventilator manipulation. Concerns have been raised that low V T ventilation may increase patient discomfort, leading to 
Summary of the Pro Position
There is very strong evidence from randomized controlled trials that the use of a 6 mL/kg V T strategy affects mortality outcome in ARDS. The routine use of a low V T strategy in all patients receiving mechanical ventilation is not yet an "official" recommendation, but evidence is mounting that the use of low V T values in patients without ARDS may add additional protection against the injurious effects of mechanical ventilation, leading to a paradigm shift from treating ARDS to the prevention of ARDS. There is convincing evidence that the use of low V T values during intra-operative ventilation protects against postoperative pulmonary complications. The role of low V T strategy in other ventilated patients without ARDS is less certain, but the evidence so far is suggestive that these patients will also derive a protective benefit from V T reduction in terms of reduction of pulmonary complication rate and improvements in outcomes. Should 6 mL/kg be the "standard" V T to be used in all patients? The answer to this is yes, keeping in mind that there may be exceptions to this standard. Although the evidence to this point in time supports the use of 6 mL/kg PBW, it is unknown whether 4 mL/kg PBW is better than 6 mL/kg PBW. All we know is that 6 mL/kg PBW is more protective than 10 -12 mL/kg PBW. However, in the absence of more elaborate measurements and with the evidence we have to this point, it makes sense to at least start ventilation with the target of 6 mL/kg PBW at the bedside. Given the unpredictability of developing ARDS during mechanical ventilation, a low V T ventilation strategy in all mechanically ventilated patients makes sense and should be used at the initiation of mechanical ventilation. The use of 6 mL/kg PBW at the onset of mechanical ventilation will help to ensure the early delivery of lung protection in patients at risk (whether it is known by the bedside clinician or not) of developing ARDS. The evidence also suggests that this practice is safe in the majority of mechanically ventilated patients.
Introduction of the Con Position
The premise that one prescription is good for all patients and conditions is, on its own, difficult to sustain. It is possible that one size fits most and that the ill effects of such a decision are so small in comparison with the benefits that it warrants blanket application. However, there are enough reasons (clinical and physiological) for why the general application of V T ϭ 6 mL/kg PBW could lead to adverse events. Not only are there conditions (eg, COPD and acidosis) where using a standard "low" V T could be deleterious, but we must remember that the only reason to scale the V T to PBW is to prevent ventilator-induced lung injury (VILI). Reconsideration of a generic V T dosage of 6 mL/kg is of particular importance in light of recent literature suggesting that scaling the V T to PBW is, not a predictor of lung injury. 60 Effect of a V T of 6 mL/kg PBW on Gas Exchange
There are several determinants of gas exchange, including the partial pressures of oxygen and carbon dioxide, lung perfusion, alveolar surface and thickness, hemoglobin levels, V T , breathing frequency, and dead space. To better understand the effect of V T , let's assume normal alveolar and blood gas partial pressures, lung perfusion, alveolar surface, and thickness. The effect of V T on gas exchange is then described by the equation for alveolar minute ventilation, V E ϭ (V T Ϫ V D ) ϫ f, where V A is minute alveolar ventilation, V D is the dead space volume, and f is breathing frequency. It becomes evident that to keep a constant V E, in the presence of a constant V T and V D , the only variable that can change is breathing frequency. Now consider that we prescribe a V T of 6 mL/kg PBW for a patient in which all physiological values (alveolar surface, perfusion, and dead space ϭ 2 mL/kg) are within normal limits. 61 The alveolar minute ventilation range within the normal to highest limits of set ventilator breathing frequency will be as follows: V E ϭ (V T Ϫ V D ) ϫ f; V E ϭ (6 mL/kg Ϫ 2 mL/kg) ϫ 10 -35 breaths/min; V E ϭ 40 -140 mL/kg/min; V E for a 70-kg man ϭ 2.8 -9.8 L/min. 62 Now, consider COPD or even acute lung injury where V D is elevated or sepsis and metabolic acidosis, where the metabolic demand requires a higher V E . 63, 64 If we increase the dead space, just by 1 mL/kg, the maximum minute ventilation that the ventilator can safely deliver decreases by 25%: V E ϭ (6 mL/kg Ϫ 3 mL/kg) ϫ 10 -35 breaths/ min; V E ϭ 30 -105 mL/kg/min; V E for a 70-kg man ϭ 2.1-7.4 L/min. Using conventional ventilation, attempting to ventilate with small V T values will lead to higher breathing frequencies and development of hypoventilation, intrinsic PEEP, hemodynamic compromise, and higher work of breathing. 62,65
Hypoventilation
As described above, the use of lower V T values frequently leads to some degree of hypercapnia (due to the restriction of breathing frequency to Ͻϳ35 breaths/min using conventional modes of ventilation). Clinicians have adopted the practice of permissive hypercapnia to avoid lung injury. This was accepted as a consequence because the effects of mild to moderate hypercapnia on various organ systems seem to be of no clinical relevance in the majority of critically ill patients. [66] [67] [68] However, the clini-cian must remember the effect of carbon dioxide in different organs and systems, which are of much relevance in specific conditions. For example, the central nervous system is extremely sensitive to carbon dioxide levels. Hypercapnia leads to an increase in cerebral blood flow, which in the setting of intracranial hypertension may be deleterious. In specific settings, such as increased intracranial pressure or ischemia, a low V T strategy could be injurious for the brain.
Another clinically relevant example is the effect on the cardiovascular system. Acute hypercapnia leads to an increase in cardiac output secondary to an increase in cardiac contractility, increased heart rate, and a reduction in systemic vascular resistance. This leads to an increase in oxygen delivery, which is further enhanced by a deviation of the oxyhemoglobin dissociation curve. In contrast, the effect of hypercapnia on the pulmonary vasculature is different. Hypercapnia causes an increase in pulmonary vascular resistance and pulmonary artery pressures by enhancing the effects of hypoxic vasoconstriction. 69, 70 With this knowledge, patients with underlying pulmonary hypertension or right heart failure may not benefit or may even be harmed when exposed to hypercapneic conditions. In summary, the implementation of strategies that may lead to hypercapnia on all critically ill patients may have deleterious effects.
Time Constant and Auto-PEEP
The time constant (s) is obtained by multiplying compliance (mL/cm H 2 O) and resistance (mL/cm H 2 O/s). The time constant describes the time required to achieve a 63% change in pressure, volume, or flow in response to a step change in inspiratory pressure under passive conditions. Figure 4 demonstrates that the lung will inflate or deflate at the same proportion for a time interval (the time constant), and in consequence, it takes 5 constants to essentially empty or fill the lung. Table 3 demonstrates this concept. In a patient with ARDS, the compliance and resistance are low; thus, the time constant is short, and the lung inflates rapidly. However, in an emphysematous lung, the time constant is prolonged (both compliance and resistance are higher); thus, a longer time is needed to empty. In table 5 you can note that at 5 constants the lung has Data from Reference 71. R ϭ resistance C ϭ compliance achieved full deflation or inflation. In ARDS this would take 2.7 s vs 5.5 s in COPD.
As the V T becomes smaller, all else being equal, the breathing frequency must increase to maintain the target minute alveolar ventilation. Patients with longer time constants who are exposed to higher breathing frequencies (mandatory or spontaneous) will develop air trapping. In fact, in obstructive disorders, the recognition and avoidance of auto-PEEP (the pressure associated with air trapping) leading to lung hyperinflation is the cornerstone in management. Tuxen et al 72 described a strategy where decreasing the amount of hyperinflation by creating hypoventilation leads to improved outcomes. This trial emphasized the importance of the time constant and allowing adequate time for expiration. In that report, the initial V T values were 10 mL/kg actual body weight (ranging from 700 to 900 mL) and respiratory the breathing frequency was limited to avoid air trapping. Interestingly, since the advent of the ARDSNet trial, guidelines and reviews for mechanical ventilation in obstructive lung disorders have been gradually decreasing V T values, despite the absence of any new work in the management of COPD. [73] [74] [75] We must not forget that air trapping and auto-PEEP leading to hemodynamic consequences occurs also in ARDS, where the time constant is considerably shorter. 76, 77 Work of Breathing Figure 5 depicts the relationship between the ventilator and the patient work of breathing according to the mode of mechanical ventilation. 78 This relationship is essential to understanding the effects of decreasing V T on the patient's work of breathing. The ventilator work of breathing will depend on the driving pressure required to achieve the desired target. When the target is volume, in the presence of patient effort, the ventilator will require less driving pressure to deliver a given V T . It follows that when lower V T values are set, the driving pressure will be lower, resulting in a shift of work toward the patient (ie, the ventilator will do less work to deliver the volume). In volume control ventilation, when the patient effort is high enough, the patient may actually breathe against the ventilator (which will not deliver more flow/volume) (see Fig. 6 ). In modes that use pressure control, in the presence of respiratory effort, the operator or the ventilator will need to decrease the inspiratory pressure to maintain the target V T . 79 As we can see, decreasing the V T size may lead to unmatched patient work of breathing. This results in increased work of breathing and asynchrony. The resolution of this has due to low V T ; with the use of higher V T in ARDS have been well described by Kallet et al. 65 In clinical practice, the presence of asynchrony related to high respiratory drive (double triggering, flow asynchrony in volume control, or excessive V T values in pressure control) may lead to use of sedation or paralysis to allow limitation of the V T and synchrony. Indeed, the analysis of studies evaluating the ARDSNet studies revealed no increase in sedation and paralytics. [57] [58] [59] However, in the context of a broad population, some with normal lungs, COPD, or severe acidosis, the utilization of sedation may be different. This poses a particular clinical challenge and may lead to prolongation of mechanical ventilation and the inherent adverse effects of oversedation and paralytics. [80] [81] [82] 
VILI
In terms of VILI, an excessive V T is a well-recognized cause of alveolar overdistention (stretch injury), alveolar wall rupture (disruption), and cyclic recruitment. 83 The ARDSNet trial was a culminating point in our understanding of VILI and led to a change in practice. 12 After the trial was published, controversy ensued regarding what component (V T or plateau pressure) was the driver of the results. Trials by Stewart et al, 11 Brochard et al, 9 and Brower et al 84 found no difference between low and high V T ventilation in subjects with ARDS. The trial by Amato et al 10 and ARMA found a lower mortality in favor of lower V T . Eichacker et al 85 pointed out that the 3 "non-beneficial" trials used V T closer to 10 mL/kg in the higher V T group, and the plateau pressures were Ͻ28 -32 cm H 2 O, whereas in the 2 "beneficial trials," the higher V T of 12 mL/kg was associated with high airway pressures (Ͼ34 cm H 2 O), and this would explain the mortality difference. [9] [10] [11] [12] 84, 85 Petrucci and Iacovelli 86 reported similar findings and showed that clinical outcome of high V T ventilation was not different from that of low V T ventilation when plateau pressure was maintained at 31 cm H 2 O or less; however, the sample size between the groups was very different (lower plateau pressure 288 subjects vs higher plateau pressure 1,009 subjects), so the results should be interpreted with caution. Guidelines and protocols suggest limiting V T at 6 mL/kg PBW and plateau pressure Ͻ30 cm H 2 O to prevent VILI. However, more recent evidence reveals that neither V T scaled to PBW nor plateau pressure are adequate surrogates for predicting outcomes. 87 How do we reconcile this with the available evidence?
Scaling
The current method to select V T dosage is to scale (normalize) it to the PBW (using height and sex), similar to the way drug dosages are calculated. This was an important contribution from the V T trials, which helped to standardize interventions across centers and made clear to everyone the V T used. 12, 84 The rationale to normalize the V T was that the lung size is defined by height rather than by weight (ie, an adult will have the same size lungs regardless of his weight). This concept makes sense in health, but the V T scaled to the height may not reflect the actual size of the lungs in disease. Gattinoni 88 made the case that in patients with acute lung injury, the normally aerated tissue was closer to the size of a "baby lung." On the opposite side of the spectrum are lungs that are larger than expected for the height due to a pathologic process. The classic example would be emphysema, in which the lungs are larger than expected for the height of the patient (ie, the aerated tissue is closer to the size of a giant's lung) (Fig.  7) . Under these circumstances, scaling V T to PBW could lead to inappropriate settings. In the case of the ARDS lung, 6 mL/kg could be too large a V T , which would lead to injury. In the case of emphysema, a 6 mL/kg would be too small, leading to increased percentage of dead space ventilation, tachypnea, and auto-PEEP.
Several groups have come to recognize that the alternative is to scale the V T to the respiratory system characteristics (compliance or elastance) rather than PBW. A pioneer in this field, Mead et al 89 described the concept of relative stress as the change in volume relative to resting size. They then elegantly studied the concept of regional stress multipliers as a source of lung injury. This concept demonstrated that under heterogeneous lung conditions, areas of alveolar collapse would generate multiplication of the wall stress in the neighboring areas. Using this rationale, current research groups have evaluated the effect of stress and strain on the lung, recognizing that scaling V T to the respiratory system characteristics may be a better predictor or marker of injurious mechanical ventilation. 13, 60, 90 Gattinoni 90 interpreted strain as the change in volume (change in size) over the functional residual capacity (resting size).
Lung injury can then be explained by excessive application of global or local stress and/or strain. Chiumello et al 87 tested this theory in an animal model of ARDS. They found that strain values in the range of 1.5-2, which corresponds to a transpulmonary pressure (stress) of 10 cm H 2 O, were the critical threshold for injury. In this study, neither V T /PBW nor plateau pressure was a marker of lung injury. More importantly, prolonged application of very large V T (27 Ϯ 3 mL/kg) without any PEEP for 2.5 d Fig. 7 . Relative size of the lung according to body size. In a patient with ARDS, the lung volume will shift down, such that for the same body size, the lungs will be smaller (as if they were from a smaller person). In a patient who develops emphysema, the lung volume shifts up, so that for the same body size, the lungs will be larger (as if they were from a larger person).
did not cause any lung injury as long as the strain was below the threshold.
A recent study by Amato et al 60 used data from 9 randomized trials evaluating mechanical ventilation in ARDS to assess whether V T normalized to the respiratory system compliance was a better predictor of injury. They used the definition of compliance (the inverse of elastance), C RS ϭ V T /⌬ P, where C RS is the compliance of the respiratory system (which includes the lung and chest wall components), V T is the tidal volume delivered above PEEP, and ⌬P is the difference between plateau pressure and set PEEP. ⌬P or driving pressure was then defined as V T /C RS .
As such, ⌬P is normalizing or scaling the V T to the respiratory system compliance. The advantage is that ⌬P is an index of both high V T and low C RS , each of which is associated with VILI. In their thoughtful analysis, ⌬P was the variable that best predicted survival. More to our point, neither V T /PBW nor plateau pressure had any predictive effect on survival or barotrauma. (eg, there was no difference in the relative risk of mortality at any level of V T /PBW from 4 to 10 mL/kg PBW).
Summary of the Con Position
In summary, limiting V T values to 6 mL/kg PBW for all patients receiving mechanical ventilation has the potential to cause harm. The blanket application could lead to increased breathing frequencies, auto-PEEP, hypoventilation, increased sedation, and unmatched work of breathing. All of these issues may be worth the price to prevent lung injury; however, new evidence on the understanding of lung injury suggests that the scaling of V T to PBW is not an accurate way of predicting risk in the first place. Thus, the concept of limiting V T to 6 mL/kg PBW needs to be reexamined in the face of the patient's condition, disease, and physiological characteristics. A simple V T dosage for all patients may not be appropriate and may lead to harm in specific cases. The risk of developing side effects is higher in patients with severe lung disease, increased respiratory drive (neurological or metabolic), increased dead space, and prolonged time constants (Tables 4 and 5 ).
Conclusions
The use of low V T strategies has been well validated in ARDS and has led to a paradigm shift in our thinking and ventilation management for these patients. We have learned that mechanical ventilation and the knobs we manipulate therein significantly affect our patients and can be injurious. This frame of mind has expanded to the realm of non-ARDS patients. There is emerging evidence that using lower V T values in surgical and non-ARDS mechanically ventilated patients may improve clinical outcomes and prevent the incidence of ARDS in high risk patients, which begs the question: Why not employ the use of V T of 6 mL/kg PBW for all patients, including those without ARDS? We must exercise some caution in taking this to the bedside. First, new evidence suggests that there may be a better way to adjust our V T values; however, more studies are needed before we should incorporate it into practice. We must keep in mind the physiology and the multiple conditions often found in the ICU, also keeping in mind that there may yet be situations where 6 mL/kg PBW may not be optimal. Also, the use of 6 mL/kg PBW does have the potential to induce hypercapnia, auto-PEEP, and patientventilator synchrony. However these conditions are manageable at the bedside in the majority of cases. There are a couple of reasons to strongly consider the use of 6 mL/kg PBW in all patients at the initiation of mechanical ventilation. The first is that pulmonary damage can happen in only a few hours after the initiation of mechanical ventilation with inappropriate settings. The second is that ARDS is frequently recognized after a delay in onset of the inflammatory process. Therefore, early use of 6 mL/kg PBW can be considered a preventive measure as opposed to a therapeutic modality. This may be especially protective in at-risk conditions, such as sepsis, trauma, transfusions, or Hurford: John, but remember that those are very abnormal conditions in the OR. Classically, FRC is reduced by 50% very quickly; there's a lot of atelectasis that occurs within 10 min of inducing anesthesia. You have increases in intra-abdominal pressure, you have release of inflammatory mediators. It's a very short time and I share your suspicion, but I don't want people to walk away thinking that the lung of a supine person with a lot of surgeons inside their belly is a normal situation. Similar to pulmonary resection, if you're taking out one lung and that remaining lung is already diseased and you're having the release of inflammatory mediators, it's a more abnormal situation than you might believe. Admittedly, if you're having a knee arthroscopy, it's going to be really hard to screw up. We've ventilated people with 10-15 mL/kg for years and years, and those folks weren't ending up in the ICU. Our pneumonectomy patients were. And the mortality rate was dramatically reduced when we changed ventilator strategies.
Marini: Bill, those are excellent points. Let's not forget the vascular side too. When you're dealing with a small lung like a single lung resection, you're pouring a lot of blood flow through that single lung and you're really upping the ante. You're absolutely right; in certain surgery patients, you have to be particularly careful. Do you measure the pressures in the anesthesia machines?
Hurford: Yes.
Marini: And keep them down?
Hurford: We do. It's hard. There's a recent study that looked at our use of lower V T values in the OR, and there was a recent study 7 from Vanderbilt looking at some academic institutions, Mayo Clinic, Partners, nearly 300,000 cases. And even in high-risk subjects, they were using Ͼ8 mL/kg about 40% of the time. It's one of these things to have very slow adoption. Everyone's confused. Normal patients probably don't need it, patients at high risk probably do; we really don't know who's at risk, so is there harm in using it on everybody? I don't know.
